Chad Hamilton to Cisplatin
This is a "connection" page, showing publications Chad Hamilton has written about Cisplatin.
Connection Strength
0.452
-
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236.
Score: 0.131
-
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells. Gynecol Oncol. 2015 Mar; 136(3):554-61.
Score: 0.112
-
Mitochondrial proteomic analysis of cisplatin resistance in ovarian cancer. J Proteome Res. 2012 Sep 07; 11(9):4605-14.
Score: 0.095
-
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Sep; 122(3):521-6.
Score: 0.088
-
Identification of candidate circulating cisplatin-resistant biomarkers from epithelial ovarian carcinoma cell secretomes. Br J Cancer. 2014 Jan 07; 110(1):123-32.
Score: 0.026